MATTHEW EDEN: Open Payments
NPI 1609408343 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 57 payments from 16 companies in 2025. Trend: 2023 $2,489 · 2024 $2,913 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 6 | $408 |
| Insulet Corporation | 19 | $275 |
| CeQur Corporation | 1 | $109 |
| Lilly USA, LLC | 5 | $98 |
| Novo Nordisk Inc | 4 | $94 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $91 |
| Corcept Therapeutics | 3 | $68 |
| Amgen Inc. | 3 | $65 |
| Amneal Pharmaceuticals LLC | 3 | $55 |
| Sequel Med Tech, LLC | 2 | $52 |
Products named: TZIELD, Omnipod, CeQur Simplicity, ISTURISA, JARDIANCE, MOUNJARO, Korlym, Ozempic.
Industry payments across FL — which companies pay providers there.
